Business News • PR NewsWire • Cell Therapeutics Announces European Launch Of Pixuvri® For Treatment Of Adult Patients With Multiply Relapsed Or Refractory Aggressive Non-Hodgkin B-Cell Lymphoma

Cell Therapeutics Announces European Launch Of Pixuvri® For Treatment Of Adult Patients With Multiply Relapsed Or Refractory Aggressive Non-Hodgkin B-Cell Lymphoma

Cell Therapeutics Announces European Launch Of Pixuvri® For Treatment Of Adult Patients With Multiply Relapsed Or Refractory Aggressive Non-Hodgkin B-Cell Lymphoma

SEATTLE, Sept. 11, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC), a company focused on translating science into novel cancer therapies, today announced the initiation of the commercial launch of Pixuvri® in the European Union ("E.U.") with entry...

View More : http://www.prnewswire.com/news-releases/cell-therapeutics-announces-european-launch-of-pixuvri-for-treatment-of-adult-pa...

Releted News by prnewswire

Mitsubishi Heavy Industries America and Federal Broach Jointly Exhibit at IMTS 2012

Cresud S.A.C.I.F. y A. Announces Results for the period FY 2012 Ended June 30, 2012